Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
21.35%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 4.95Close
$ 2.73 - $ 8.07 52-Week Range
Ticker Information
Ticker
VYGRCompany Name
VOYAGER THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVOYAGER THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VYGR - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 6.6M | 21.35% | $ 30.91M |
| 3/31/2025 | $ 5.77M | 9.54% | $ 60.48M |
| 12/31/2024 | $ 4.73M | 5.91% | $ 80M |
| 9/30/2024 | $ 5.05M | 3.09% | $ 163.78M |
| 6/30/2024 | $ 4.87M | 3.39% | $ 143.77M |
| 3/31/2024 | $ 4.56M | 3.83% | $ 119.04M |
| 12/31/2023 | $ 4.44M | 1.78% | $ 250.01M |
| 9/30/2023 | $ 3.94M | 2.49% | $ 158.4M |
| 6/30/2023 | $ 4.34M | 2.23% | $ 194.87M |
| 3/31/2023 | $ 4.45M | 2.34% | $ 190.73M |
Key Performance Insights, Last 5 Years
- VOYAGER THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 1.82%.
- Over the past 5 years, VOYAGER THERAPEUTICS INC's average DepAmor % has been 8.85%.
- The median DepAmor % for VOYAGER THERAPEUTICS INC during this period was 3.62%
- VOYAGER THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 29.41%.
- The lowest DepAmor % recorded by VOYAGER THERAPEUTICS INC in the same timeframe 1.78%
VOYAGER THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for VOYAGER THERAPEUTICS INC is calculated as follows: DepAmor [ $ 3.59M ] / Revenues [ $ 197.26M ]
(=) DepAmor % [ 1.82% ] VYGR - Depreciation and Amortization Margin, Last 5 years
1.78%
Minimum
Dec 31, 2023
29.41%
Maximum
Sep 30, 2021
8.85%
Average
3.62%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |